AbbVie, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 44,350 | $9,292,212 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 8, 2025 |
| June 30, 2025 | 38,725 | $7,188,135 | 0.12% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2025 |
| Sept. 30, 2025 | 38,725 | $8,966,387 | 0.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 38,725 | $8,848,275 | 0.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 4, 2026 |
| March 31, 2026 | 38,725 | $8,422,300 | 0.17% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 4, 2026 |
| June 30, 2026 | 38,795 | $9,762,374 | 0.18% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 5, 2026 |
| Sept. 30, 2026 | 38,795 | $10,148,384 | 0.19% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 5, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.